GGrantIndex
← Leaderboards

Daniel G Miller

University Of Washington

$6,682,294
Attributed
$6,682,294
Total exposure
6
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $917.4K · FY200518
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18

Funding mix

By agency

NIH$6,682,294 · 6

By mechanism

R01$4,414,773 · 3
P01$1,201,256 · 1
K08$626,265 · 1
R56$440,000 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Washington

Same institution · by research overlap

Others in their field

Top investigators on “Design

Research focus

DesignGenesCellsResearch StudyAllelesTranscriptGenetic TranscriptionTreatment StrategyProteinsPhenotypePathway InteractionsMutationAffectGene ExpressionVectorTissuesCell LineChromatinMyoblastsRepressionLifeEpigenetic ProcessMediatingHaplotypes

Grant awards (25)

Epigenetic Modifiers of D4Z4 in Facioscapulohumeral Muscular Dystrophy (FSHD)$382,800
R01 · FY2018 · AR · contact PI
Chromatin Modifications that modulate DUX4 expression in FSHD$440,000
R56 · FY2017 · AR · contact PI
Epigenetic Modifiers of D4Z4 in Facioscapulohumeral Muscular Dystrophy (FSHD)$382,800
R01 · FY2017 · AR · contact PI
Epigenetic Modifiers of D4Z4 in Facioscapulohumeral Muscular Dystrophy (FSHD)$382,800
R01 · FY2016 · AR · contact PI
Epigenetic Modifiers of D4Z4 in Facioscapulohumeral Muscular Dystrophy (FSHD)$382,800
R01 · FY2015 · AR · contact PI
Epigenetic Modifiers of D4Z4 in Facioscapulohumeral Muscular Dystrophy (FSHD)$382,800
R01 · FY2014 · AR · contact PI
Keratin Gene Targeting for the Treatment of Epidermolysis Bullosa$311,780
R01 · FY2014 · AR · contact PI
FSH-Patient Derived IPS Cells to Study the Developmental Regulation of DUX4 Trans$222,826
P01 · FY2014 · NS · contact PI
Keratin Gene Targeting for the Treatment of Epidermolysis Bullosa$302,236
R01 · FY2013 · AR · contact PI
FSH-Patient Derived IPS Cells to Study the Developmental Regulation of DUX4 Trans$230,721
P01 · FY2013 · NS · contact PI
Keratin Gene Targeting for the Treatment of Epidermolysis Bullosa$318,144
R01 · FY2012 · AR · contact PI
FSH-Patient Derived IPS Cells to Study the Developmental Regulation of DUX4 Trans$241,818
P01 · FY2012 · NS · contact PI
Keratin Gene Targeting for the Treatment of Epidermolysis Bullosa$318,142
R01 · FY2011 · AR · contact PI
FSH-Patient Derived IPS Cells to Study the Developmental Regulation of DUX4 Trans$247,228
P01 · FY2011 · NS · contact PI
Keratin Gene Targeting for the Treatment of Epidermolysis Bullosa$330,804
R01 · FY2010 · AR · contact PI
FSH-Patient Derived IPS Cells to Study the Developmental Regulation of DUX4 Trans$258,663
P01 · FY2010 · NS · contact PI
AAV Vector Integration Frequency and Associated Genome Alterations$227,027
R01 · FY2010 · DK · contact PI
AAV Vector Integration Frequency and Associated Genome Alterations$229,320
R01 · FY2009 · DK · contact PI
AAV Vector Integration Frequency and Associated Genome Alterations$229,320
R01 · FY2008 · DK · contact PI
AAV Vector Integration Frequency and Associated Genome Alterations$234,000
R01 · FY2007 · DK · contact PI
Mechanisms of Cellular Transduction with AAV Vectors$125,253
K08 · FY2006 · DK · contact PI
Mechanisms of Cellular Transduction with AAV Vectors$125,253
K08 · FY2005 · DK
Mechanisms of Cellular Transduction with AAV Vectors$125,253
K08 · FY2004 · DK
Mechanisms of Cellular Transduction with AAV Vectors$125,253
K08 · FY2003 · DK
Mechanisms of Cellular Transduction with AAV Vectors$125,253
K08 · FY2002 · DK